Optiver Holding’s NovoCure NVCR Stock Holding History

Optiver Holding’s Portfolio NVCR Stock Details NVCR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$708	Buy	+65	New	+$812	﹤0.01%	2115
2025 Q4	–	Sell	-626	Closed	-$8.09K	–	2819
2025 Q3	$8.09K	Buy	626 +480	+329%	+$6.41K	﹤0.01%	1428
2025 Q2	$2.6K	Buy	146 +108	+284%	+$1.88K	﹤0.01%	1323
2025 Q1	$677	Buy	+38	New	+$863	﹤0.01%	1294

Other funds holding NVCR

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

QCM

Quantinno Capital Management New York $59.9B AUM 28.07% 1-Year Est. Return

Optiver Holding's NVCR Position: Q1 2026 in Review

Optiver Holding opened a new position in NovoCure (NVCR) in Q1 2026: 65 shares worth $708. The stake represents ﹤0.01% of the portfolio and ranks #2115 among its holdings. This is a return to the name: Optiver Holding previously reported a position in NVCR as recently as Q3 2025.

Optiver Holding first reported a position in NVCR in Q1 2025 and has held it in 4 quarters since. The position peaked at $8.09K in Q3 2025. 222 funds tracked by Wall St. Rank hold NVCR as of Q1 2026.

Optiver Holding held 65 shares of NovoCure worth $708 as of Q1 2026.
NovoCure was a new Optiver Holding position in Q1 2026.
NovoCure made up ﹤0.01% of Optiver Holding's portfolio in Q1 2026, its #2115 holding.
Optiver Holding first reported a position in NovoCure in Q1 2025 and has held it in 4 quarters since.
Optiver Holding's NovoCure position peaked at $8.09K in Q3 2025.
222 funds tracked by Wall St. Rank held NovoCure as of Q1 2026.

Based on Optiver Holding's 13F filing for Q1 2026, filed 15 May 2026.